Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.
Costa DB, Nguyen KS, Cho BC, Sequist LV, Jackman DM, Riely GJ, Yeap BY, Halmos B, Kim JH, Jänne PA, Huberman MS, Pao W, Tenen DG, Kobayashi S.
Costa DB, et al. Among authors: pao w.
Clin Cancer Res. 2008 Nov 1;14(21):7060-7. doi: 10.1158/1078-0432.CCR-08-1455.
Clin Cancer Res. 2008.
PMID: 18981003
Free PMC article.